PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Repro Med Systems, Inc. (KRMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS7599101026
CUSIP759910102
SectorHealthcare
IndustryMedical Instruments & Supplies

Highlights

Market Cap$95.99M
EPS-$0.30
PE Ratio16.29
PEG Ratio2.40
Revenue (TTM)$28.52M
Gross Profit (TTM)$15.37M
EBITDA (TTM)-$9.40M
Year Range$1.98 - $4.48
Target Price$3.70
Short %3.35%
Short Ratio12.64

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with KRMD

Repro Med Systems, Inc.

Popular comparisons: KRMD vs. LUNA, KRMD vs. UFPT

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Repro Med Systems, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%OctoberNovemberDecember2024FebruaryMarch
169.61%
1,762.29%
KRMD (Repro Med Systems, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Repro Med Systems, Inc. had a return of -7.33% year-to-date (YTD) and -45.70% in the last 12 months. Over the past 10 years, Repro Med Systems, Inc. had an annualized return of 29.36%, outperforming the S&P 500 benchmark which had an annualized return of 10.96%.


PeriodReturnBenchmark
Year-To-Date-7.33%10.04%
1 month10.98%3.53%
6 months-17.57%22.79%
1 year-45.70%32.16%
5 years (annualized)7.32%13.15%
10 years (annualized)29.36%10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-15.27%1.92%
20230.77%3.05%-15.93%-0.44%8.63%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Repro Med Systems, Inc. (KRMD) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
KRMD
Repro Med Systems, Inc.
-0.92
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Repro Med Systems, Inc. Sharpe ratio is -0.92. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.92
2.76
KRMD (Repro Med Systems, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Repro Med Systems, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-81.68%
0
KRMD (Repro Med Systems, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Repro Med Systems, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Repro Med Systems, Inc. was 98.59%, occurring on Apr 3, 2003. Recovery took 2692 trading sessions.

The current Repro Med Systems, Inc. drawdown is 81.68%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.59%Apr 29, 19871664Apr 3, 20032692Dec 29, 20174356
-84.3%Apr 28, 2020537Jun 13, 2022
-48.44%Mar 9, 20208Mar 18, 202021Apr 17, 202029
-23.2%Jan 2, 201813Jan 19, 201819Feb 16, 201832
-21.99%May 14, 201827Jun 21, 201860Sep 19, 201887

Volatility

Volatility Chart

The current Repro Med Systems, Inc. volatility is 18.96%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%OctoberNovemberDecember2024FebruaryMarch
18.96%
2.82%
KRMD (Repro Med Systems, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Repro Med Systems, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items